| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.09 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.46 | 0.1 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.096 | 0.1 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |